In the clinic for June 11, 2026
AI Briefing
- • Cullinan announces positive Phase III data for its biopharma treatment.
- • Lophora's new med tech product receives FDA clearance for clinical trials.
- • Molecular's publication presents groundbreaking findings on cancer treatment efficacy.
Context
Clinical updates are being provided for biopharma and med tech companies. The updates include data readouts and publications from several companies, including Cullinan, Lophora, Molecular, Nexalin, Sanofi, and SPR.
These updates matter for those in the biopharma and med tech fields who require access to the latest information on data readouts and publications from these companies, but the information is only available to those with paid plans.
Advertisement